![Meeting Cybin FDA Meeting](https://psychedelicmedicalnews.com/wp-content/uploads/2024/08/Meeting-500x300.jpg)
Cybin
![Meeting Cybin FDA Meeting](https://psychedelicmedicalnews.com/wp-content/uploads/2024/08/Meeting-500x300.jpg)
![Atul Mahableshwarkar Atul Mahableshwarkar](https://psychedelicmedicalnews.com/wp-content/uploads/2024/06/Atul-Mahableshwarkar--500x300.jpg)
Cybin Appoints Atul Mahableshwarkar as Senior VP, Clinical Development
![Cybin Patent Cybin Patent](https://psychedelicmedicalnews.com/wp-content/uploads/2024/04/Cybin-Patent-500x300.jpg)
Cybin Receives New Patent for Psilocybin Depression Treatment
![Cybin Stock Offering Cybin Stock Offering $150 Million](https://psychedelicmedicalnews.com/wp-content/uploads/2024/03/Cybin-Stock-Offering-500x300.jpg)
Cybin Raises $150 Million Via Oversubscribed Private Placement
![FDA HQ FDA](https://psychedelicmedicalnews.com/wp-content/uploads/2024/02/FDA-HQ-500x300.jpg)
After ‘Positive’ FDA Meeting, Cybin Looks Ahead to Phase 3 CYB003 Program
![Psilocybin Cybin CYB003 Psilocybin](https://psychedelicmedicalnews.com/wp-content/uploads/2024/03/Psilocybin-500x300.jpg)